Core Laboratories Joint Venture Agreement
VIBGYOR Scientific Research, genae associates, Cardiovascular Center Aalst and J.B. Dahm, MD have reached an agreement to form a Core Laboratories joint venture, called imaeon.
Core Laboratories joint venture agreement between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm
6 October 2008 - Antwerp, Ahmedabad, Aalst, Göttingen
VIBGYOR Scientific Research, genae associates, Cardiovascular Center Aalst and J.B. Dahm, MD have reached an agreement to form a Core Laboratories joint venture, called imaeon.
imaeon initially will focus on the performance of medical images analysis for clinical research projects, including but not limited to: quantitative coronary and peripheral angiography (QCA, QVA), computed tomography (CT) angiography, intravascular ultrasound (IVUS) and IVUS related
techniques, multiple gated acquisition scan (MUGA), optical coherence tomography (OCT), magnetic resonance imaging (MRI), multi slice computer tomography (MSCT), electrocardiogram (ECG) and ECHO assessments.
While meeting or exceeding all quality standards in a timely and cost-effective manner, imaeon will offer expert evaluations of medical images from multi-modality environments and unsurpassed quality clinical research services. It will operate from the main facilities and offices in Ahmedabad,
India and from the subsidiary in Antwerp, Belgium and focus on the pharmaceutical, biomedical and medical device industries.
About Cardiovasculair Onderzoek Aalst CVBA
Cardiovasculair Onderzoek Aalst, with principal offices in Aalst, Belgium, provides consultancy assignments and logistics support related to scientific research and scientific studies for physicians, hospitals, universities, pharmaceutical institutions, governments and governmental institutions.
Contact
Paul Nellens, MD - paul.nellens@olvz-aalst.be
About genae associates nv
genae is a privately held NV/SA with principal offices in Antwerp, Belgium and is ISO 9001:2000 certified for CRO, Core Laboratories and Services Provider for the Medical Industries. These global services include but are not limited to Clinical Data Management, Electronic Data Capture
(EDC), Statistical Analysis, Scientific & Medical Writing, CE-Marking (MDD) and Training & Education.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
